Targeting the ATR-CHK1 Axis in Cancer Therapy

Author： Rundle Stuart   Bradbury Alice   Drew Yvette   Curtin Nicola J.  

Publisher： MDPI

E-ISSN： 2072-6694|9|5|41-41

ISSN： 2072-6694

Source： Cancers, Vol.9, Iss.5, 2017-04, pp. : 41-41

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the insulin-like growth factor axis as a cancer therapy

By Haddad Tufia   Yee Douglas  

Future Oncology, Vol. 2, Iss. 1, 2006-02 ,pp. : 101-110

Future Medicine

Access to resources Recommend Favorite

Chk1 Inhibitors for Novel Cancer Treatment

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 6, Iss. 4, 2006-07 ,pp. : 377-388

Bentham Science Publishers

Access to resources Recommend Favorite

Chk1 knockdown confers radiosensitization in prostate cancer stem cells

By Wang Xiaobin   Ma Zhikun   Xiao Zheng   Liu Hui   Dou Zhongling   Feng Xiaoshan   Shi Haijun  

Oncology Reports, Vol. 28, Iss. 6, 2012-12 ,pp. : 2247-2254

Spandidos Publications

Access to resources Recommend Favorite

Targeting neddylation in cancer therapy

By Duncan Kristal   Schäfer Georgia   Vava Akhona   Parker M Iqbal   Zerbini Luiz F  

Future Oncology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1461-1470

Future Medicine

Access to resources Recommend Favorite

Targeting Telomerase for Cancer Therapy

By  

Current Cancer Therapy Reviews, Vol. 7, Iss. 3, 2011-08 ,pp. : 215-226

Bentham Science Publishers

Access to resources Recommend Favorite